ORGANOGENESIS HOLDINGS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
ORGANOGENESIS HOLDINGS INC. (ORGO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $39.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-05-07
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $39.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $18.80M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $10.01M.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $5.12M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2026-03-31 | $39.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $18.80M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.01M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.12M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $11.32M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.28M 10-K · filed 2025-02-27 |
| 2024-09-30 | $3.16M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.88M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.17M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $9.23M 10-K · filed 2024-02-29 |
| 2023-09-30 | $4.80M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $5.32M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.48M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.25M 10-K · filed 2023-03-01 |
| 2022-09-30 | $3.03M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $7.41M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $28.57M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $37.62M 10-K · filed 2022-03-01 |
| 2021-09-30 | $66.23M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $85.58M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $96.75M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $33.31M 10-K · filed 2021-03-16 |
| 2020-09-30 | $12.84M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $12.90M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $9.71M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $20.60M 10-K · filed 2020-03-09 |
| 2019-09-30 | $32.80M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $40.21M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $33.18M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $33.10M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |